James E Dentzer insider trades

Open-market stock purchases and sales by James E Dentzer, Director at Imunon, Inc, from SEC Form 4 filings since Feb 14, 2014.

Recent trades

DateStockTradeValue
Jul 31, 2026IMNN Imunon, IncBought (not open market)$11K
Jul 7, 2026CRIS Curis IncBought (not open market)$582K
May 22, 2026IMNN Imunon, IncBought (not open market)$24.5K
Mar 20, 2026CRIS Curis IncBought (not open market)—
Mar 20, 2026CRIS Curis IncBought (not open market)—
Mar 17, 2026CRIS Curis IncBought (not open market)—
Mar 17, 2026CRIS Curis IncBought (not open market)$100K
Jan 2, 2026IMNN Imunon, IncBought (not open market)—

Companies traded

  • IMNN Imunon, Inc: other filings, last Jul 31, 2026
  • CRIS Curis Inc: 8 sales, last Jul 7, 2026
  • DRNA Dicerna Pharmaceuticals Inc: other filings, last Jan 9, 2015

Get free alerts when James E Dentzer files a new trade →